• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TRP 0.00% 42.0¢

TISSUE REPAIR LTD - News & Media

Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company... Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company developing second generation wound healing agents. The Company's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The Company is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.More

(20min delay)
Last
42.0¢
Change
0.000(0.00%)
Mkt cap ! $25.39M
Open High Low Value Volume
41.5¢ 43.0¢ 39.0¢ $102.0K 248.3K

Buyers (Bids)

No. Vol. Price($)
1 352 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
41.5¢ 1500 1
View Market Depth
Last trade - 15.44pm 30/08/2024 (20 minute delay) ?
Last
42.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
42.0¢ 42.5¢ 39.0¢ 64832
Last updated 15.44pm 30/08/2024 ?
TRP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.